An ad hoc planning committee will plan and conduct a public workshop that will explore commonalities across neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and frontotemporal dementia, and identify potential opportunities for collaboration across the respective research and development communities. Participants will be invited from academia; pharmaceutical and biotechnology industries; government agencies such as the National Institutes of Health, the National Science Foundation, and the Department of Veterans Affairs; and patient advocacy groups. Looking across the neurodegenerative diseases, workshop presentations and discussions will
• Identify and discuss commonalities related to genetic and cellular mechanisms.
• Identify areas of fundamental science needed to facilitate therapeutics development.
• Explore areas of potential collaboration among the respective research communities and sponsors.
An individually authored workshop summary will be prepared based on the information gathered and the discussions held during the workshop in accordance with institutional policy and procedures.